Evidence map›Paper›PMID 35348921›Full record

ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2023

The goal of risk equalization in regulated competitive health insurance markets.

Wynand van de Ven, Gerrit Hamstra, Richard van Kleef, Mieke Reuser, Piet Stam

Abstract read
In one paragraph

Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Risk equalization and prevention.The European journal of health economics : HEPAC : health economics in prevention and care · 2026
    Article
  2. A critical review of the use of RThe European journal of health economics : HEPAC : health economics in prevention and care · 2025
    Review
  3. Risk adjustment for regional healthcare funding allocations with ensemble methods: an empirical study and interpretation.The European journal of health economics : HEPAC : health economics in prevention and care · 2024
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wynand van de VenErasmus University Rotterdam, Rotterdam, The Netherlands. vandeven@eshpm.eur.nl.ORCID http://orcid.org/0000-0001-9076-3308
Gerrit HamstraEqualis Strategy and Modeling, Utrecht, The Netherlands.
Richard van KleefErasmus University Rotterdam, Rotterdam, The Netherlands.
Mieke ReuserErasmus University Rotterdam, Rotterdam, The Netherlands.
Piet StamEqualis Strategy and Modeling, Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Different opinions exist about the goal of risk equalization in regulated competitive health insurance markets. There seems to be consensus that an element of the goal of risk equalization is 'to remove the predictable over- and undercompensations of subgroups of insured' or, equivalently, 'to achieve a level playing field for each risk composition of an insurer's portfolio' or, equivalently, 'to remove the incentives for risk selection'. However, the role of efficiency appears to be a major issue: should efficiency also be an element of the goal of risk equalization, or should it be a restriction to the goal, or should efficiency not be an element of the goal or a restriction to the goal? If efficiency plays a role, a comprehensive analysis of the total effect of risk equalization on efficiency needs to be done. An improvement of the performance of a risk equalization scheme has both negative and positive effects on efficiency. Negative effects include the reduction in efficiency via cost- or utilization-based risk adjusters. Positive effects result from leveling the playing field and reducing the incentives for risk selection, which increase efficiency as the outcome of a competitive market. In practice many regulators and policy makers take efficiency into consideration by looking at the negative effects, but hardly at the positive effects. The definition of the goal of risk equalization has consequences for the design and evaluation of risk equalization schemes and for the equalization payments. We describe relevant potential goals, tradeoffs and possible solutions.

Indexed as

GoalsMotivationAdministrative PersonnelHumansInsurance, HealthRisk AdjustmentEfficiencyLevel playing fieldRisk equalizationRisk selection

Identifiers

PMID35348921
PMCPMC9877069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.